Literature DB >> 18701939

Ischemic Preconditioning And Myocardial Infarction: An Update and Perspective.

Eric R Gross1, Garrett J Gross.   

Abstract

Myocardial infarction is the leading cause of mortality in Western societies with annual expenditures of $431.8 billion spent on coronary artery disease in man. Therapeutics to combat infarction from myocardial injury, based on studies of ischemic preconditioning (IPC), are currently in progress. Hence, this review provides an update on IPC, including general and molecular mechanisms responsible for IPC and the effects of IPC in models of aging or disease. A summary of therapeutics shown to possess efficacy in preclinical and clinical trials and future directions of studies regarding cardiac IPC are also discussed.

Entities:  

Year:  2007        PMID: 18701939      PMCID: PMC2515553          DOI: 10.1016/j.ddmec.2007.10.005

Source DB:  PubMed          Journal:  Drug Discov Today Dis Mech        ISSN: 1740-6765


  43 in total

1.  p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning.

Authors:  Mihaela M Mocanu; Derek M Yellon
Journal:  FEBS Lett       Date:  2003-12-04       Impact factor: 4.124

2.  Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes.

Authors:  Anne Hamacher-Brady; Nathan R Brady; Roberta A Gottlieb
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

3.  PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning.

Authors:  Zheqing Cai; Gregg L Semenza
Journal:  Circ Res       Date:  2005-11-10       Impact factor: 17.367

Review 4.  Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury.

Authors:  Roberto Bolli; Buddhadeb Dawn; Yu-Ting Xuan
Journal:  Trends Cardiovasc Med       Date:  2003-02       Impact factor: 6.677

5.  Ischemic preconditioning-mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice.

Authors:  Sankar Addya; Keisuke Shiroto; Tibor Turoczi; Lijun Zhan; Shigeaki Kaga; Shoji Fukuda; Saul Surrey; Li-Juan Duan; Guo-Hua Fong; Fumio Yamamoto; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2005-01-26       Impact factor: 5.000

6.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

Authors:  Derek J Hausenloy; Helen L Maddock; Gary F Baxter; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

7.  STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning.

Authors:  Genbu Yamaura; Tibor Turoczi; Fumio Yamamoto; M A Q Siddqui; Nilanjana Maulik; Dipak K Das
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

8.  Effect of classic preconditioning and diazoxide on endothelial function and O2- and NO generation in the post-ischemic guinea-pig heart.

Authors:  Andrzej Beresewicz; Michal Maczewski; Monika Duda
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

Review 9.  Signaling pathways in ischemic preconditioning.

Authors:  James M Downey; Amanda M Davis; Michael V Cohen
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

10.  Ischemic preconditioning targets the reperfusion phase.

Authors:  Derek J Hausenloy; Abigail M Wynne; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2007-05-29       Impact factor: 17.165

View more
  13 in total

1.  Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels.

Authors:  Garrett J Gross; Anna Hsu; Kasem Nithipatikom; Adam W Pfeiffer; Irina Bobrova; Erik Bissessar
Journal:  Pharmacology       Date:  2012-07-18       Impact factor: 2.547

2.  Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion-induced mitochondrial dysfunction in rat small intestine.

Authors:  Yajun Liu; Theodore Kalogeris; Meifang Wang; Mozow Yusof Zuidema; Qun Wang; Hongyan Dai; Michael J Davis; Michael A Hill; Ronald J Korthuis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-15       Impact factor: 4.052

Review 3.  Targeting of adenosine receptors in ischemia-reperfusion injury.

Authors:  Victor E Laubach; Brent A French; Mark D Okusa
Journal:  Expert Opin Ther Targets       Date:  2010-11-29       Impact factor: 6.902

4.  Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.

Authors:  Donald A Vessey; Luyi Li; Norman Honbo; Joel S Karliner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-31       Impact factor: 4.733

Review 5.  Cellular and molecular neurobiology of brain preconditioning.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Mol Neurobiol       Date:  2009-01-20       Impact factor: 5.590

6.  Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.

Authors:  Ha Won Kim; Husnain K Haider; Shujia Jiang; Muhammad Ashraf
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

7.  Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart.

Authors:  Kavita Garg; Harlokesh N Yadav; Manjeet Singh; P L Sharma
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

8.  Profiling of cell stress protein expression in cardiac tissue of cardiosurgical patients undergoing remote ischemic preconditioning: implications for thioredoxin in cardioprotection.

Authors:  Karina Zitta; Patrick Meybohm; Matthias Gruenewald; Jochen Cremer; Kai D Zacharowski; Jens Scholz; Markus Steinfath; Martin Albrecht
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

9.  Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Matthias Gruenewald; Fabian Lauer; Markus Steinfath; Jochen Cremer; Kai Zacharowski; Martin Albrecht
Journal:  J Transl Med       Date:  2014-04-08       Impact factor: 5.531

Review 10.  Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.

Authors:  A Lochner; E Marais; S Genade; B Huisamen; E F du Toit; J A Moolman
Journal:  Cardiovasc J Afr       Date:  2009 Jan-Feb       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.